drugset / Trial / NCT01590446

A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

NCT01590446

Phase 1 Completed 74 enrolled BioMarin Pharmaceutical
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to measure how much of the study drug gets into the blood- stream and how long it takes the body to get rid of it when given as a single dose. Information about any side effects that may occur will also be collected.

Timeline

Start
2012-02
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vosoritide Peptide Subcutaneous

Indications